Protocol No.: COG-AALL1731

Title
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
Principal Investigator
Paul, Stephan
Phase
III
Age Group
Both
Applicable Disease Site
Leukemia
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Jan Rapp
Clinical Trials Manager
Phone: +1 304-293-1229
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
April Shay, MSN, PNP-BC
Nurse Practitioner
Phone: +1 304-293-1217
Christy Glass, MSN
APRN
Phone: +1 304-598-4835
Denise Casino
Clinical Trials Manager
Phone: +1 304-293-0735

View on ClinicalTrials.gov